The field of oncology is experiencing rapid and ongoing transformations driven by groundbreaking advances in genomics, proteomics, oncogenic pathways, and therapeutic innovations. These paradigm shifts are reshaping cancer diagnosis, treatment, and survivorship care. Staying abreast of the latest evidence-based practices is essential for optimizing patient outcomes and fostering collaborative cancer care.
This interprofessional continuing education activity brings together physicians, advanced practice registered nurses, oncology nurses, physician associates/assistants, pharmacists, and healthcare professionals across disciplines. The conference is intentionally designed to enhance communication, collaboration, and synergy across the cancer care team, while strengthening team-based approaches to patient care.
Through didactic presentations, case-based panels, and interactive panel discussions, attendees will gain critical insights into the latest scientific, clinical, and supportive care advancements. The program also addresses cross-cutting issues such as survivorship, burnout among healthcare professionals, integrative medicine, and the ethical integration of artificial intelligence in oncology practice.
Upon completion of this activity, participants will be better able to:
Evaluate the latest evidence and treatment advances in solid tumors and hematologic malignancies, including breast, lung, gastrointestinal, genitourinary, gynecologic, and skin cancers.
Apply emerging knowledge of tumor biology, including genomic and biomarker-driven data, to personalize cancer therapies across multiple tumor types.
Integrate immunotherapies, targeted agents, and other novel therapies into practice, balancing efficacy with toxicity and supportive care strategies.
Collaborate effectively within interprofessional teams to address cancer survivorship, patient-reported outcomes, and quality-of-life concerns—especially in women’s health and mental health domains.
Identify and manage adverse effects and complications from new treatments, using best practices in supportive care and timely interventions.
Discuss the role of artificial intelligence, informatics, and value-based care frameworks in enhancing oncology practice and care delivery.
Recognize and address wellness challenges and burnout in oncology professionals, incorporating integrative and institutional strategies to foster resilience and sustainability in the healthcare workforce.
Survivorship, Women’s Health, and Wellness in Oncology: fertility preservation, menopause and sexual health, psychosocial care, burnout prevention, and integrative approaches to anxiety and depression.
Value-Based Oncology and Innovation: implementing value-based care models, using informatics and AI to enhance outcomes, and updates in head and neck cancers and melanoma.
Genitourinary and Gynecologic Malignancies: personalized therapies in prostate, bladder, kidney, cervical, uterine, and ovarian cancers, including rare histologies.
Gastrointestinal and Sarcoma Oncology: new treatments for esophageal, gastric, colorectal, pancreas, liver, biliary, and GIST tumors.
Lung Cancer: integrating novel immunotherapy and precision medicine strategies in small cell and non-small cell lung cancers.
Breast Cancer: individualizing treatment in early-stage and metastatic settings, with focus on hormone receptor-positive, HER2-positive, and triple-negative subtypes.
Hematologic Malignancies: real-world case discussions on myeloma, leukemias, lymphomas, and bone marrow transplantation.
This symposium promotes interprofessional collaboration by encouraging shared learning, discussion of challenging cases, and multidisciplinary strategies for improving cancer care delivery.
This interprofessional activity is designed for physicians, advanced practice registered nurses, oncology nurses, physician assistants, pharmacists, and professionals in training from these disciplines to build a stronger collaborative partnership with other members of the cancer care team as well as oncology specialists.